|
HK1042251B
(en)
|
1999-01-13 |
2012-07-20 |
Bayer Healthcare Llc |
Omega-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
|
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
|
EP1478358B1
(en)
|
2002-02-11 |
2013-07-03 |
Bayer HealthCare LLC |
Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
|
|
US6995143B2
(en)
|
2002-02-28 |
2006-02-07 |
Basilea Pharmaceutica Ag |
Macrolides with antibacterial activity
|
|
US6727229B2
(en)
|
2002-08-19 |
2004-04-27 |
Enanta Pharmaceuticals, Inc. |
11,12-substituted lactone ketolide derivatives having antibacterial activity
|
|
US6720308B1
(en)
|
2002-11-07 |
2004-04-13 |
Enanta Pharmaceuticals, Inc. |
Anhydrolide derivatives having antibacterial activity
|
|
HRP20020886A2
(en)
*
|
2002-11-11 |
2005-06-30 |
PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. |
SUBSTITUTED 9a-N-[N'-(BENZENSULFONYL)CARBAMOYL-γ-AMINOPROPYL) AND 9a-N(N' -(?-CYANOETHIL)-N' -(b
|
|
HRP20020991A2
(en)
*
|
2002-12-12 |
2005-02-28 |
Pliva-Istra�iva�ki institut d.o.o. |
N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
|
|
PT1626714E
(en)
|
2003-05-20 |
2007-08-24 |
Bayer Pharmaceuticals Corp |
DIARILURIES FOR PDGFR MEDICATED DISEASES
|
|
US6774115B1
(en)
|
2003-06-05 |
2004-08-10 |
Enanta Pharmaceuticals, Inc. |
6-O-substituted bicyclic ketolides
|
|
US6765016B1
(en)
|
2003-06-05 |
2004-07-20 |
Enanta Pharmaceuticals, Inc. |
Bicyclic ketolide derivatives
|
|
US6790835B1
(en)
|
2003-06-05 |
2004-09-14 |
Enanta Pharmaceuticals, Inc. |
Bicyclic macrolide derivatives
|
|
US6716820B1
(en)
|
2003-06-05 |
2004-04-06 |
Enanta Pharmaceuticals, Inc. |
6-O-substituted bicyclic macrolides
|
|
DE602004010407T2
(en)
|
2003-07-23 |
2008-10-16 |
Bayer Pharmaceuticals Corp., West Haven |
FLUORO-SUBSTITUTED OMEGA-CARBOXYARYLDIPHENYL-UREA FOR THE TREATMENT AND PREVENTION OF DISEASES AND SUFFERING
|
|
CA2533824A1
(en)
*
|
2003-07-31 |
2005-02-10 |
Irm, Llc |
Bicyclic compounds and compositions as pdf inhibitors
|
|
EP1658285B1
(en)
*
|
2003-08-20 |
2007-05-02 |
Eli Lilly And Company |
Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
|
|
WO2005019184A1
(en)
|
2003-08-20 |
2005-03-03 |
Eli Lilly And Company |
Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
|
|
RU2403237C2
(en)
*
|
2004-05-14 |
2010-11-10 |
Эмисфире Текнолоджис, Инк. |
Compositions and mixtures for delivery of active agents
|
|
HRP20100253T1
(en)
|
2004-12-21 |
2010-06-30 |
Pfizer Products Inc. |
macrolides
|
|
CN101115764B
(en)
*
|
2005-02-09 |
2012-09-26 |
巴斯利尔药物股份公司 |
New macrolides
|
|
EP1879903A1
(en)
|
2005-05-10 |
2008-01-23 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
Ether linked macrolides useful for the treatment of microbial infections
|
|
JPWO2007105581A1
(en)
*
|
2006-03-10 |
2009-07-30 |
土田 裕三 |
Antimicrobial agent and antimicrobial composition
|
|
EP2077271A4
(en)
*
|
2006-05-01 |
2010-09-15 |
Taisho Pharmaceutical Co Ltd |
MAKROLITDERIVAT
|
|
JP2010501541A
(en)
*
|
2006-08-24 |
2010-01-21 |
ウォックハート リサーチ センター |
Novel macrolides and ketolides with antibacterial activity
|
|
JP2010501567A
(en)
|
2006-08-24 |
2010-01-21 |
ノバルティス アクチエンゲゼルシャフト |
2- (pyrazin-2-yl) -thiazole and 2- (1H-pyrazole-3-) as stearoyl-CoA desaturase (SCD) inhibitors for the treatment of metabolic, cardiovascular and other disorders Yl) thiazole derivatives and related compounds
|
|
EP2066664A1
(en)
|
2006-09-22 |
2009-06-10 |
Novartis AG |
Heterocyclic organic compounds
|
|
CN101595105B
(en)
|
2006-12-20 |
2013-01-23 |
诺瓦提斯公司 |
2-substituted 5-membered heterocycles as SCD inhibitors
|
|
US20110230428A1
(en)
*
|
2008-07-22 |
2011-09-22 |
John Wityak |
Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
US20120041194A1
(en)
*
|
2008-08-29 |
2012-02-16 |
Triad Multitech Pharmaceuticals, Inc. |
Nitrogen and sulfur-containing hetrocycle derivatives
|
|
RU2011153353A
(en)
|
2009-05-27 |
2013-07-10 |
Вокхардт Рисерч Сентер |
KETOLIDE COMPOUNDS WITH ANTI-MICROBIAL ACTIVITY
|
|
WO2012008549A1
(en)
|
2010-07-15 |
2012-01-19 |
武田薬品工業株式会社 |
Heterocyclic ring compound
|
|
CN102417530A
(en)
*
|
2010-09-26 |
2012-04-18 |
中国医学科学院药物研究所 |
Synthesis method of broad spectrum antibiotics erythromycin A macrocyclic ketolide derivatives and application
|
|
KR101657751B1
(en)
*
|
2010-12-09 |
2016-09-19 |
욱크하르트 리미티드 |
Ketolide compounds
|
|
WO2012117357A2
(en)
|
2011-03-01 |
2012-09-07 |
Wockhardt Limited |
Process for preparation of ketolide intermediates
|
|
BR112014004845A2
(en)
|
2011-08-30 |
2017-04-04 |
Chdi Foundation Inc |
at least one chemical entity; at least one compound; pharmaceutical composition; use of a therapeutically effective amount of at least one chemical entity; packaged pharmaceutical composition
|
|
EP3243515B1
(en)
|
2011-08-30 |
2019-10-16 |
CHDI Foundation, Inc. |
Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
|
|
US8940742B2
(en)
*
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
ES2900806T3
(en)
|
2013-10-04 |
2022-03-18 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds and uses thereof
|
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
SG10201808053XA
(en)
|
2014-03-19 |
2018-10-30 |
Infinity Pharmaceuticals Inc |
Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
|
|
EA034528B1
(en)
|
2014-07-17 |
2020-02-17 |
Сиэйчдиай Фаундэйшн, Инк. |
Method for treating hiv-related disorders
|
|
WO2016054491A1
(en)
|
2014-10-03 |
2016-04-07 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
KR20160061743A
(en)
|
2014-11-24 |
2016-06-01 |
주식회사 엘지화학 |
Super absorbent polymer and preparation method thereof
|
|
JP6980649B2
(en)
|
2015-09-14 |
2021-12-15 |
インフィニティー ファーマシューティカルズ， インコーポレイテッド |
The solid form of the isoquinolinone derivative, the method for producing it, the composition containing it, and the method for using it.
|
|
WO2017161116A1
(en)
|
2016-03-17 |
2017-09-21 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as pi3k kinase inhibitors
|
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
|
WO2021111124A1
(en)
|
2019-12-02 |
2021-06-10 |
Storm Therapeutics Limited |
Polyheterocyclic compounds as mettl3 inhibitors
|
|
CN110272417B
(en)
*
|
2019-06-18 |
2021-07-13 |
五邑大学 |
2-Methyl-1,8-naphthyridine compound and its preparation method and application
|
|
US11999703B1
(en)
|
2023-10-25 |
2024-06-04 |
King Faisal University |
5-(2,4,5-tris(4-chlorophenyl)-1H-imidazol-1-yl)pentanoic acid as an antimicrobial compound
|